Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cardiac resynchronization therapy: from treatment to prevention

Cardiac resynchronization therapy: from treatment to prevention TRIPLE EDITORIAL European Heart Journal (2011) 32, 1580–1582 doi:10.1093/eurheartj/ehr016 Cardiac resynchronization therapy: from treatment to prevention 1 2 Christophe Leclercq and Jagmeet P. Singh 1 2 CHU Rennes, Service de Cardiologie et Maladies Vasculaires, INSERM, CIC-IT, 35000 Rennes, France; and Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, USA Online publish-ahead-of-print 14 February 2011 This editorial refers to ‘Response to preventive cardiac As the patient population eligible for CRT continues to expand, resynchronization therapy in patients with ischaemic and together with the fact that a substantial proportion of patients nonischaemic cardiomyopathy in MADIT-CRT’ ,by remain non-responsive to CRT, it is imperative that we attempt A. Barsheshet et al., on page 1622, ‘Time-dependent to better define responders and non-responders to CRT, as well benefit of preventive cardiac resynchronization therapy as address the cost-effectiveness of this therapeutic intervention. after myocardial infarction’ , by A. Barsheshet et al.,on The results from the REVERSE, MADIT-CRT, and RAFT trials page 1614, and ‘Cost-effectiveness of cardiac resyncroniza- showed some uniformity in that a QRS duration of .150 ms 5,6 tion therapy in patients with asymptomatic to mild heart was predictive of a favourable response to CRT. The failure: insights from the European cohort http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Heart Journal Oxford University Press

Cardiac resynchronization therapy: from treatment to prevention

Loading next page...
 
/lp/oxford-university-press/cardiac-resynchronization-therapy-from-treatment-to-prevention-BAgtnWWlRs

References (17)

Publisher
Oxford University Press
Copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2011. For permissions please email: journals.permissions@oup.com
Subject
EDITORIAL
ISSN
0195-668X
eISSN
1522-9645
DOI
10.1093/eurheartj/ehr016
pmid
21324935
Publisher site
See Article on Publisher Site

Abstract

TRIPLE EDITORIAL European Heart Journal (2011) 32, 1580–1582 doi:10.1093/eurheartj/ehr016 Cardiac resynchronization therapy: from treatment to prevention 1 2 Christophe Leclercq and Jagmeet P. Singh 1 2 CHU Rennes, Service de Cardiologie et Maladies Vasculaires, INSERM, CIC-IT, 35000 Rennes, France; and Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, USA Online publish-ahead-of-print 14 February 2011 This editorial refers to ‘Response to preventive cardiac As the patient population eligible for CRT continues to expand, resynchronization therapy in patients with ischaemic and together with the fact that a substantial proportion of patients nonischaemic cardiomyopathy in MADIT-CRT’ ,by remain non-responsive to CRT, it is imperative that we attempt A. Barsheshet et al., on page 1622, ‘Time-dependent to better define responders and non-responders to CRT, as well benefit of preventive cardiac resynchronization therapy as address the cost-effectiveness of this therapeutic intervention. after myocardial infarction’ , by A. Barsheshet et al.,on The results from the REVERSE, MADIT-CRT, and RAFT trials page 1614, and ‘Cost-effectiveness of cardiac resyncroniza- showed some uniformity in that a QRS duration of .150 ms 5,6 tion therapy in patients with asymptomatic to mild heart was predictive of a favourable response to CRT. The failure: insights from the European cohort

Journal

European Heart JournalOxford University Press

Published: Jul 14, 2011

There are no references for this article.